CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
Tumor mutational burden (TMB) is one of the most significant predictive biomarkers of immunotherapy efficacy in non-small cell lung cancer (NSCLC). Radiomics allows high-throughput extraction and analysis of ...
Source: BMC Medical Imaging - Category: Radiology Authors: Jiexiao Wang, Jialiang Wang, Xiang Huang, Yanfei Zhou, Jian Qi, Xiaojun Sun, Jinfu Nie, Zongtao Hu, Shujie Wang, Bo Hong and Hongzhi Wang Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Radiology